Liberty Health Sciences Opens 28th Dispensary in Lake City Continuing the Company's Expansion Across Florida
TORONTO, Dec. 11, 2020 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a Florida licensed medical marijuana provider of high-quality cannabis, announced today that it has opened its 28th retail location in Lake City, Florida.
Liberty Lake City, located at 1720 W. US Highway, carries the full Liberty Health Sciences suite of cannabis brands that are tailored to provide patients with the best quality-of-life wellness products. Designed to offer a comfortable educational and shopping experience, the store has 2,573 square feet of space with an additional waiting area and private consultation room. The dispensary's operating hours are Monday through Friday, 10 a.m. to 7 p.m., Saturday, 10 a.m. to 5 p.m., and Sunday, 12 p.m. to 5 p.m. The dispensary also showcases original paintings and photographs from local artists on a rotating basis.
"We are excited to resume the opening of new locations to continually provide ever better access for patients to our services statewide," said George Gremse, interim CEO of Liberty Health Sciences. "Lake City, in north central Florida, will be followed by the opening of a dispensary in Ft. Meyers, in southwest Florida, in January."
Following Ft. Meyers, Liberty plans to strategically open three more dispensaries by the end of February 2021 and an additional 10 stores throughout the rest of 2021, for a total of 42 locations throughout Florida, subject to approval from the Florida Department of Health.
Patients may place an order online at www.libertyhealthsciences.com for in-store pick-up or delivery.
About Liberty Health Sciences Inc.
Liberty Health Sciences is an integrated "seed-to-sale" company that provides medical marijuana products to patients throughout the State of Florida. All its cultivation and processing is done at its 387-acre Gainesville, Florida facility. Patients purchase products either through Liberty's statewide network of dispensaries or via company provided home delivery. Liberty's stock trades in the United States on the OTCQX market under the symbol LHSIF and on the Canadian Securities Exchange under the symbol LHS. For more information, please visit: www.libertyhealthsciences.com
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains certain forward-looking statements within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "believe", "plan", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, expectations related to the Company's production capabilities, expectations concerning the receipt of all necessary approvals from the Florida Department of Health, expectations concerning the opening of new dispensaries and the expansion of its greenhouse space, and the Company's future expansion and growth strategies. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the medical marijuana industry in the United States generally, income tax and regulatory matters; the ability of Liberty to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions, or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
SOURCE Liberty Health Sciences Inc.
Media Contacts: Dwain Schenck, (203) 223-5230, [email protected]; George Gremse, Interim CEO, [email protected]
Share this article